Salbutamol

ApprovedSmall molecule

GSK

Salbutamol is one of 517 small molecule programs targeting Insulin resistance. It is currently in Approved.

Indications

101

Total Trials

Active Trials

516

Competitors

Pipeline

Status by Indication[3][1]

Indication

Insulin ResistanceActive, not recruiting

HyperkalemiaActive, not recruiting

BronchiolitisActive, not recruiting

Liver TransplantActive, not recruiting

Status AsthmaticusActive, not recruiting

BronchiectasisActive, not recruiting

Hypersensitivity PneumonitisActive, not recruiting

Airway ObstructionActive, not recruiting

MyopathyActive, not recruiting

Renal ColicActive, not recruiting

Insulin ResistancePreclinical

Active, not recruiting

HyperkalemiaApproved

Active, not recruiting

BronchiolitisPreclinical

Active, not recruiting

Liver TransplantPreclinical

Active, not recruiting

Status AsthmaticusApproved

Active, not recruiting

BronchiectasisPreclinical

Active, not recruiting

Hypersensitivity PneumonitisPreclinical

Active, not recruiting

Airway ObstructionPreclinical

Active, not recruiting

MyopathyPreclinical

Active, not recruiting

Renal ColicPreclinical

Active, not recruiting

Showing 10 of 23 indications

Competition

Competitive Landscape

1051 competitors in Asthma

#DrugCompanyPhaseTrials

Salbutamol

GSK

Approved

30 2

Singulair

AstraZeneca

Preclinical

17 3

Cinqair

Teva

Preclinical

13 4

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Preclinical

30 5

Asmanex

Novartis

Preclinical

5 6

Arcoxia

Symbicort

6 8

Aciphex

Akero Therapeutics

Preclinical

2 9

Atrovent

Boehringer Ingelheim

Preclinical

2 10

Decadron

QQuince Therapeutics S.p.A.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

N/ANot yet recruiting

Women

NCT06426082

Phase 3Active, not recruiting

Trial

NCT05527704

Q4 2026

Recruiting

Wheezing

NCT06093152

Q4 2027

N/AActive, not recruiting

Dilation

NCT03522831

Q4 2030

N/ARecruiting

Screening

NCT07037511

Clinical

Trials by Indication[1]

Asthma30 trials

Comparison of RPL554 With Placebo and Salbutamol in Asthmatic Patients

Completed·VVerona Pharma plc·Phase 2·NCT02427165·29 enrolled

Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy Subjects

Completed·UUnknown Sponsor·Phase 4·NCT03044938·15 enrolled

Viapaed Study In Children And Adolescents With Asthma

Completed· GSK logo

GSK·Phase 4·NCT00315744·285 enrolled

Show 27 more trials

Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma

Completed· GSK logo

GSK·Phase 3·NCT02502734·60 enrolled

Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma

Unknown status·AAssistance Publique - Hôpitaux de Paris··NCT03592212·99 enrolled

Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma

Completed·MMedical University of Lodz·Phase 4·NCT00487773·96 enrolled

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With Asthma

Completed· AstraZeneca logo

AstraZeneca·Phase 3·NCT00384189·1,080 enrolled

Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)

Completed·UUniversity of British Columbia·Phase 4·NCT05087693·18 enrolled

Measurement of Respiratory Admittance for Pediatric Asthma Diagnosis

Completed·—·Phase 4·NCT02877537·177 enrolled

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma

Completed· GSK logo

GSK·Phase 4·NCT04276233·100 enrolled

Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in Children

Completed·SSuez Canal University·Phase 3·NCT03816267·60 enrolled

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

Completed· GSK logo

GSK·Phase 2·NCT00358488·54 enrolled

As Needed Beclomethasone/Salbutamol Combination in Single Inhaler for Mild Persistent Asthma

Completed· Chiesi Farmaceutici S.p.A. logo

Chiesi Farmaceutici S.p.A.·Phase 3·NCT00382889·480 enrolled

A Safety and Efficacy Study of Mepolizumab in Subjects With Severe Asthma

Completed· GSK logo

GSK·Phase 3·NCT03562195·300 enrolled

The Regulatory Function of Inhaled Asthma Medication Salbutamol on Thermogenesis

Not yet recruiting·TTongji University·Phase 1·NCT06319183·30 enrolled

Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room

Completed· Otsuka logo

Otsuka·Phase 4·NCT01091337·96 enrolled

Results Of Patient Rated Asthma Control Test In Comparison To Diary Card Data

Completed· GSK logo

GSK·Phase 4·NCT00363480·221 enrolled

Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-week Treatment Period of Adult Patients With Uncontrolled Asthma

Completed· Chiesi Farmaceutici S.p.A. logo

Chiesi Farmaceutici S.p.A.·Phase 3·NCT00528723·180 enrolled

A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children

Completed·—·Phase 4·NCT06918418·60 enrolled

Single Dose Study to Assess Efficacy, Safety and Tolerability of LAS100977 in Asthmatic Patients.

Completed· AstraZeneca logo

AstraZeneca·Phase 2·NCT01425801·62 enrolled

The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children

Completed·TThe Hospital for Sick Children··NCT02743663·121 enrolled

A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma

Completed· AstraZeneca logo

AstraZeneca·Phase 2·NCT02479412·54 enrolled

CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in Asthma

Active, not recruiting·UUniversità degli Studi di Ferrara·Phase 2·NCT06482294·80 enrolled

Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics

Completed·UUniversity of North Carolina, Chapel Hill·N/A·NCT03556683·24 enrolled

Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma

Completed· GSK logo

GSK·Phase 3·NCT01687296·261 enrolled

Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms

Completed· Chiesi Farmaceutici S.p.A. logo

Chiesi Farmaceutici S.p.A.·Phase 3·NCT00497523·283 enrolled

The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary Outcome

Completed·OOman Medical Speciality Board·Phase 4·NCT05667727·30 enrolled

A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects

Completed· GSK logo

GSK·Phase 4·NCT03380429·437 enrolled

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children

Terminated· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 4·NCT02235428·3 enrolled

A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma

Completed· GSK logo

GSK·Phase 3·NCT03184987·111 enrolled

Chronic Obstructive Pulmonary Disease7 trials

A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore:

Completed· AstraZeneca logo

AstraZeneca·Phase 3·NCT01313494·626 enrolled

High-flow Nasal Cannula Nebulization of Beta 2 Adrenergic Agonist During Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Unknown status·PPoitiers University Hospital·Phase 3·NCT03449056·25 enrolled

Inhaler Lung Deposition in Chronic Obstructive Pulmonary Disease (COPD)

Completed·IImperial College London·Phase 4·NCT01721291·65 enrolled

Show 4 more trials

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients

Completed·UUniversity Hospital, Antwerp·Phase 4·NCT00911651·6 enrolled

Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Completed· Novartis logo

Novartis·Phase 3·NCT00669617·89 enrolled

Bronchoprotection of Salbutamol in Asthma and Chronic Obstructive Pulmonary Disease

Completed·UUniversity of Saskatchewan·Phase 4·NCT00440245·28 enrolled

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Completed· Novartis logo

Novartis·Phase 4·NCT01922271·152 enrolled

Wheezing2 trials

Efficacy of Intermittent Tiotropium in Early Childhood Wheezing

Terminated·HHelsinki University Central Hospital·Phase 4·NCT03199976·80 enrolled

Video Assisted Study of Salbutamol Response in Viral Wheezing

Recruiting·UUniversity of Oulu··NCT06093152·50 enrolled

Tics2 trials

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects

Completed·EEnterprise Therapeutics Ltd·Phase 1·NCT04488705·80 enrolled

Salbutamol, Pharmacogenetics and Breathing Mechanics

Completed·UUniversity of British Columbia·Phase 4·NCT01903785·94 enrolled

Mechanical Ventilation2 trials

Effectiveness of Routine Nebulization of Mucolytics and Bronchodilators During Mechanical Ventilation

Completed·—·N/A·NCT02159196·950 enrolled

Evaluation of Aerosolized Drugs Deposition During Mechanical Ventilation

Completed·—·N/A·NCT02818270·30 enrolled

53 more indications

Adult2 trials

Bronchodilator Responsiveness in Healthy Young Adults Using Forced Oscillations Technique (FOT)

Completed·UUniversity of Patras·N/A·NCT01067534·100 enrolled

The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.

Completed·UUniversity of Aarhus·Phase 4·NCT02914652·96 enrolled

Hyperkalemia2 trials

5 Versus 10 Units of Insulin in Hyperkalemia Management

Completed·OOman Medical Speciality Board·Phase 4·NCT06036823·384 enrolled

Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia

Recruiting·NNantes University Hospital·Phase 4·NCT04012138·525 enrolled

Tachypnea2 trials

Role of Salbutamol in the Management of Transient Tachypnea of the New Born

Completed·KKhyber Teaching Hospital·Phase 1·NCT06921291·60 enrolled

Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN)

Completed·AAhmed Noaman·Phase 1·NCT05006235·135 enrolled

Cognitive Functions1 trial

Influence of Salbutamol on Emotional and Cognitive Functions in Healthy Subjects

Completed·PProf. Dominique de Quervain, MD·Phase 2·NCT01957293·40 enrolled

Hypertrophy1 trial

Chronic Beta2-adrenergic Stimulation and Cardiac and Skeletal Muscle Hypertrophy

Completed·UUniversity of Copenhagen·N/A·NCT02551276·42 enrolled

Screening1 trial

Effects of Salbutamol in Athletes and Implications for Screening and Sports

Recruiting·UUniversity of British Columbia·N/A·NCT07037511·64 enrolled

Bronchiectasis1 trial

Evaluating Bronchodilator Response in Patients With Bronchiectasis

Unknown status·RRambam Health Care Campus·N/A·NCT05932316·96 enrolled

Exercise1 trial

Physiological Response to Salbutamol and Exercise

Unknown status·UUniversity of Copenhagen·N/A·NCT03902106·40 enrolled

Bronchiolitis1 trial

Nebulized Epinephrine vs. Salbutamol in Bronchiolitis Among Children

Completed·MMakassed General Hospital·N/A·NCT03814954·90 enrolled

Congestive Heart Failure1 trial

Use of Beta-agonists in Stable Severe Congestive Heart Failure

Unknown status·RRabin Medical Center·N/A·NCT01447069·30 enrolled

Drug1 trial

IPF Drug Deposition Study

Completed·RRoyal Brompton & Harefield NHS Foundation Trust·Phase 1·NCT01457261·10 enrolled

Medication1 trial

The Effects of RPL554 on Top of Standard COPD Reliever Medications

Completed·VVerona Pharma plc·Phase 2·NCT02542254·36 enrolled

Dilation1 trial

CF Bronchodilation

Active, not recruiting·UUniversity of British Columbia·N/A·NCT03522831·20 enrolled

Pilot Study1 trial

Sensor and Electronic Health Records (EHR) Integration Pilot Study

Completed· GSK logo

GSK··NCT03357341·194 enrolled

Drug Repurposing1 trial

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic Antagonists

Completed·—··NCT05457868·124,117 enrolled

Liver Transplant1 trial

Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation

Unknown status·FFirst Affiliated Hospital Xi'an Jiaotong University·N/A·NCT05589441·100 enrolled

Status Asthmaticus1 trial

Status Asthmaticus on the PICU; Intravenous Salbutamol

Completed·EErasmus Medical Center·Phase 4·NCT03493503·58 enrolled

Imaging1 trial

Helium-3 MRI Imaging Study in COPD

Completed· GSK logo

GSK·Phase 1·NCT02207452·11 enrolled

Pneumonia1 trial

Effectiveness Study of Integrative Treatment for Pediatric Pneumonia

Completed·LLiaoning University of Traditional Chinese Medicine·N/A·NCT02069665·451 enrolled

Ventilation1 trial

Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD

Completed·ZZhujiang Hospital·N/A·NCT02296047·22 enrolled

Muscle Performance1 trial

The Effect of High Dose Salbutamol on Muscle Performance

Unknown status·—·N/A·NCT01415596·20 enrolled

ALS1 trial

Effect of Salbutamol on Walking Capacity in Ambulatory ALS Patients

Not yet recruiting·AAssistance Publique - Hôpitaux de Paris·Phase 2·NCT05860244·36 enrolled

Children1 trial

Bronchodilators for Wheeze in Young Children Presenting to Primary Care: a Randomised, Placebo-controlled, Multicentre, Parallel Group Trial

Withdrawn·UUMC Utrecht·Phase 4·NCT04584034

Tolerance1 trial

Salbutamol Tolerance Onset

Completed·UUniversity of Saskatchewan·Phase 4·NCT01338311·15 enrolled

Renal Colic1 trial

Nebulized Salbutamol in Acute Renal Colic

Not yet recruiting·OOman Medical Speciality Board·N/A·NCT06276231·214 enrolled

Adverse Effect1 trial

Comparison of Preoperative Inhaled Budesonide With Salbutamol on the Respiratory Adverse Effects in Children Undergoing Tonsillectomy

Unknown status·—·Phase 4·NCT06158893·87 enrolled

Bariatric Surgery1 trial

Effect of Intraoperative Salbutamol Administration on Mechanical Power and Respiratory Mechanics in Obese Patients Undergoing Laparoscopic Bariatric Surgery

Not yet recruiting·SSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital·N/A·NCT07378605·66 enrolled

Cardiac Repolarization1 trial

Nebulized Bronchodilators and Cardiac Repolarization

Completed·MMedical University of Gdansk·N/A·NCT01714401·50 enrolled

Outcome1 trial

Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

Unknown status·HHenan University of Traditional Chinese Medicine·Phase 3·NCT03745261·240 enrolled

Myopathy1 trial

Changes of Motor Function Tests in Congenital Myopathy Subjects Treated With Oral Salbutamol as Compared to no Treatment

Completed·VVastra Gotaland Region·N/A·NCT05099107·18 enrolled

Cardiovascular1 trial

Cardiovascular Consequences of Inhaled Short-acting Beta-agonist Use

Completed·UUniversity of Alberta·Phase 1·NCT06027606·81 enrolled

Effectiveness1 trial

A Randomized Comparative Effectiveness Research Trial of Three Treatments for COPD Patients

Unknown status·HHenan University of Traditional Chinese Medicine·Phase 3·NCT01836016·360 enrolled

Corticosteroids1 trial

Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD

Completed·SSyntara·Phase 2·NCT00117182·140 enrolled

Hypertension1 trial

HaemoDYNAMICs in Primary and Secondary Hypertension

Unknown status·TTampere University··NCT01742702·2,000 enrolled

Myasthenia Gravis1 trial

Beta-agonist Efficacy and Tolerability as Adjuvant Therapy in Myasthenia Gravis

Unknown status·UUniversity of Aarhus·Phase 2/3·NCT03914638·30 enrolled

Efficacy1 trial

Efficacy of SLITone in House Dust Mite Allergic Patients

Completed·AALK-Abelló A/S·Phase 2/3·NCT00633919·124 enrolled

Hypersensitivity Pneumonitis1 trial

Small Airway Involvement in Patients With Chronic Hypersensitivity Pneumonitis

Completed·UUniversity of Sao Paulo General Hospital·N/A·NCT02523833·27 enrolled

Moderate to Severe COPD1 trial

A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPD

Completed· Novartis logo

Novartis·Phase 4·NCT02371629·776 enrolled

Abdominal pain1 trial

INhaled Salbutamol vs Placebo for the Treatment of Acute IgE-mediated Abdominal Pain From Allergic Food REactions

Terminated·PPhilippe Bégin·Phase 3·NCT05653024·24 enrolled

Pulmonary Tuberculosis1 trial

Rapid Diagnosis of Pulmonary Tuberculosis

Unknown status·UUniversity of Cape Town·N/A·NCT00608790·600 enrolled

Trial1 trial

the Inhaled β2-adrenergic Receptor Agonist for Transient Tachypnoea of the Newborn (the REFSAL Trial)

Active, not recruiting·MMedical University of Warsaw·Phase 3·NCT05527704·608 enrolled

Child1 trial

Study of Dose-response to Bronchodilator and Dose-finding in Child 2.5 to 6 Years - Study Golden

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 2·NCT01470755·90 enrolled

Central Nervous System1 trial

Beta2-mimetic and Central Nervous System

Completed·UUniversity Hospital, Grenoble·N/A·NCT02925130·15 enrolled

Caesarean Section1 trial

Inhaled Salbutamol in Elective Caesarean Section

Unknown status·SSture Andersson·Phase 4·NCT01978418·62 enrolled

Propranolol1 trial

Optimising the Propranolol Block Model

Completed· GSK logo

GSK·Phase 1·NCT00549120·18 enrolled

Airway obstruction1 trial

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)

Unknown status·HHat Yai Medical Education Center·N/A·NCT05550402·60 enrolled

Budesonide1 trial

Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations

Completed· AstraZeneca logo

AstraZeneca·Phase 4·NCT00272753·20 enrolled

Insulin resistance1 trial

Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle

Completed·UUniversity of Copenhagen·N/A·NCT04558190·10 enrolled

Nebulization1 trial

Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.

Completed·UUniversity Hospital, Tours·Phase 2·NCT01958814·43 enrolled

Women1 trial

Deciphering a Novel and Unique Brown Adipose Tissue Depot in Women

Not yet recruiting·—·N/A·NCT06426082·40 enrolled

Adolescent1 trial

Effect of Fluticasone Furoate/Vilanterol on EIA in Adolescents

Completed·RRambam Health Care Campus·Phase 4·NCT04750603·92 enrolled

Pompe Disease1 trial

Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease

Completed·NNational Taiwan University Hospital·Phase 4·NCT02405598·14 enrolled

Unspecified3 trials

Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm

Completed· Boehringer Ingelheim logo

Boehringer Ingelheim·Phase 4·NCT02182713·30 enrolled

Rapid Onset Action of Salbutamol Versus Formoterol

Unknown status·—·Phase 4·NCT00900874·78 enrolled

Physiologic Performance Response to Salbutamol

Unknown status·UUniversity of Copenhagen·N/A·NCT04615611·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 101 trial records for Salbutamol. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Salbutamol compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Salbutamol. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: GSK

Salbutamol

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Q4 2026

Q4 2027

Q4 2030

Trials by Indication[1]

Asthma30 trials

Chronic Obstructive Pulmonary Disease7 trials

Wheezing2 trials

Tics2 trials

Mechanical Ventilation2 trials

Adult2 trials

Hyperkalemia2 trials

Tachypnea2 trials

Cognitive Functions1 trial

Hypertrophy1 trial

Screening1 trial

Bronchiectasis1 trial

Exercise1 trial

Bronchiolitis1 trial

Congestive Heart Failure1 trial

Drug1 trial

Medication1 trial

Dilation1 trial

Pilot Study1 trial

Drug Repurposing1 trial

Liver Transplant1 trial

Status Asthmaticus1 trial

Imaging1 trial

Pneumonia1 trial

Ventilation1 trial

Muscle Performance1 trial

ALS1 trial

Children1 trial

Tolerance1 trial

Renal Colic1 trial

Adverse Effect1 trial

Bariatric Surgery1 trial

Cardiac Repolarization1 trial

Outcome1 trial

Myopathy1 trial

Cardiovascular1 trial

Effectiveness1 trial

Corticosteroids1 trial

Hypertension1 trial

Myasthenia Gravis1 trial

Efficacy1 trial

Hypersensitivity Pneumonitis1 trial

Moderate to Severe COPD1 trial

Abdominal pain1 trial

Pulmonary Tuberculosis1 trial

Trial1 trial

Child1 trial

Central Nervous System1 trial

Caesarean Section1 trial

Propranolol1 trial

Airway obstruction1 trial

Budesonide1 trial

Insulin resistance1 trial

Nebulization1 trial

Women1 trial

Adolescent1 trial

Pompe Disease1 trial

Unspecified3 trials

References

Drug Info

Quick Facts

Related News